Sitagliptin for Reducing Inflammation and Immune Activation
Clinical trial NCT02513771 · COMPLETED
Trial details
- NCT number
- NCT02513771
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-12-13
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.